Drug Shortage Report for SANDOZ ALFACALCIDOL
Report ID | 248199 |
Drug Identification Number | 02533324 |
Brand name | SANDOZ ALFACALCIDOL |
Common or Proper name | ALFACALCIDOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ALFACALCIDOL |
Strength(s) | 1MCG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100SGC |
ATC code | A11CC |
ATC description | VIT A AND D, INCL COMBINATIONS OF THE TWO |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-09-09 |
Estimated end date | 2025-02-21 |
Actual end date | 2025-02-10 |
Shortage status | Resolved |
Updated date | 2025-02-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-02-11 | English | Compare |
v4 | 2025-02-10 | French | Compare |
v3 | 2025-02-10 | English | Compare |
v2 | 2025-01-21 | French | Compare |
v1 | 2025-01-21 | English | Compare |
Showing 1 to 5 of 5